The Annual Medication Review

Once a year, put every pill you take on a table with a clinician and ask three questions. That single visit addresses the most common reversible contributors to cognitive decline in older adults — and unlike almost everything else on this site, it is a conversation, not a workout. This page is the how-to: why the list grows on its own, what your clinician is looking for, and the red flags that mean the review should not wait for the calendar.

The One-Visit Question

The parent topic introduced this page's core idea, and it deserves its own walk-through because it is the cheapest cognitive intervention on the site. The question is not a single sentence — it is a small script you bring to a clinician once a year, with every medication, supplement, and over-the-counter product you actually take:

Why this works is structural. Cognitive decline from medication is usually a slow accumulation — the anticholinergic page showed the risk lives in years of daily use, not in any single pill. An annual checkpoint finds the accumulation while it is still small, and while the alternatives are still simple.

Why the List Grows on Its Own

Nobody plans to take eight medications. The list assembles itself through a few well-documented processes:

• 🔗 The prescribing cascade. Drug A causes a side effect that looks like a new condition, so Drug B is prescribed to treat it — a documented driver of unnecessary polypharmacy.
• 🏥 Multiple prescribers. A cardiologist, a urologist, and a sleep clinic each add one medication — none of them sees the combined list.
• 💊 The invisible half. Over-the-counter products and supplements rarely make it into the chart, yet they carry real pharmacology — diphenhydramine sleep aids, NSAIDs, and herbal sedatives included.
• 🔄 Transitions. Hospital discharges and specialist handoffs are where medications get added, duplicated, and never retired — "started in the hospital" is a common origin story for pills nobody still needs.
• 🕰️ Aging itself. Kidney and liver clearance slow with age, so a dose that was right at 55 can be excessive at 75 — the body changes even when the prescription does not.

The Cognitive Angle

This page sits in the Cognitive pillar for a reason: among older adults, medications are among the most common reversible causes of cognitive complaints. The classic presentation is fog, word-finding trouble, or confusion that arrived slowly and matches a medication timeline — and the classic amplifier is alcohol on top of sedating medications, which the alcohol page covers. When a clinician sees new cognitive complaints, the medication list is reviewed before the memory clinic referral, because fixing the list sometimes fixes the complaint.

The stakes run in both directions: medications that quietly impair cognition while taken, and medication reductions that can restore it. The honest scope note — stopping a medication does not guarantee recovery, and some cognitive damage from long exposure may not fully reverse. The review is about stopping the accumulation, early.

The Tools Clinicians Use

You do not need to learn these — your clinician already has them. Knowing they exist makes the conversation easier:

• 📖 The Beers Criteria — the American Geriatrics Society's periodically updated list of medications that are potentially inappropriate in older adults, organized by concern (cognition, falls, kidneys) (AGS, 2023).
• 🛑 STOPP/START — a European twin toolset: STOPP flags medications that should be stopped; START flags useful medications that are missing (O'Mahony et al., Age and Ageing, 2015).
• 🧮 The ACB scale — the anticholinergic burden scoring the benzodiazepine-anticholinergic page explains; several mild blockers can sum to a heavy load.
• 🔎 Deprescribing frameworks — structured, evidence-informed approaches to reducing medications safely, used by geriatricians and increasingly by primary care.

How to Run the Review

Logistics that make it real: a pharmacist-led medication review is an option in many countries and often free; in the US, the Medicare Annual Wellness Visit includes a medication review component. Time it to the quarterly audit if you already run one — the medication pass slots naturally into that routine. Bring a partner or a written list if your memory is part of the concern; the visit should not depend on the very faculty it exists to protect. And carry an up-to-date copy of the list in your wallet — the emergency-department version of this review happens at 3 a.m., and the list is the difference between a complete medication history and a guessing game.

When Something Gets Stopped

Deprescribing — the deliberate, supervised removal of medications — is the review's payoff, and it has its own discipline (Page et al., Maturitas, 2016). The principles are consistent across guidelines: change one medication at a time, reduce slowly ("start low, go slow"), and watch for both withdrawal and the return of the condition being treated. The taper rule page explains why some of these drugs — benzodiazepines especially — must never be stopped abruptly.

The evidence for deprescribing is honest but not heroic: it reliably reduces medication counts and adverse events, with more modest effects on cognition and falls in the trials that measured them. That is still a good trade — fewer pills, fewer interactions, fewer falls — and the direction of every signal is the same.

Red Flags That Skip the Calendar

The annual schedule is for maintenance. Some developments mean the review happens this week:

• 🚨 New confusion or memory trouble — especially when it follows a medication change or a new prescription.
• 🚨 A fall, or near-falls — sedating and blood-pressure medications are the usual suspects, and the next fall may not be a near-miss.
• 🚨 Daytime sedation or "brain fog" — the signature of accumulated sedative and anticholinergic load.
• 🚨 Anyone in the household asking "are you okay?" — outside observers notice medication effects before the person taking them does.

If any of these apply, contact a clinician and say exactly that: new cognitive symptoms plus a medication list you want reviewed. That one sentence moves the timeline from next year to next week — which, for a reversible problem, is the whole game.

Questions, Answered Briefly

• 🗓️ Do I really need this every year? Not if you take nothing — the value scales with the size of the list. The convention is annual for anyone on several medications, and any year can be the one that catches the accumulation.
• 👨‍⚕️ Which clinician should do it? Whoever prescribes most of the list — usually primary care — with a pharmacist review as a strong complement. The key is one person seeing the whole list.
• 💊 Should supplements be on the list? Yes — they are pharmacology without a prescription pad, and the nootropic audit shows why unregulated does not mean harmless.
• 📉 What if a medication still feels necessary? Then the review's job is to keep it, at the right dose, with monitoring — not to shrink the list for its own sake.
• 🩺 What if my clinician says no? Ask for the reason — sometimes the medication is genuinely load-bearing. A good clinician explains; a great one documents the review so next year starts ahead.

Related Topics